drugset / Trial / NCT04694989

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)

NCT04694989

Phase 1 Completed 62 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-386

Timeline

Start
2021-02-20
Primary completion
2021-04-07
Completion
2021-05-04

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-386 Unknown Oral
Subject D013 Unknown Oral
Subject D326 Unknown Oral
Subject D337 Unknown Oral